20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Altimmune (NASDAQ:ALT) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Altimmune beat estimated earnings by 16.67%, reporting an EPS of $-0.4 versus an estimate of $-0.48.
Revenue was down $11 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 4.29% drop in the share price the next day.
Here's a look at Altimmune's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.50 | -0.50 | -0.51 | -0.58 |
| EPS Actual | -0.43 | -0.48 | -0.42 | -0.44 |
| Revenue Estimate | 30K | 870K | 870K | 1.03M |
| Revenue Actual | -110K | 2K | 8K | 32K |
To track all earnings releases for Altimmune visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!